Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because ...
Learn the correct pronunciation of the Irbesartan and Hydrochlorothiazide , understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, ...
A drug company announced on Friday that eight lots of Irbesatan blood pressure medication have been recalled after testing showed the medication contained trace amounts of a cancer-causing material.
Rockville, MD - The US FDA Cardiovascular and Renal Drugs Advisory Committee recommended extended use of the combination product irbesartan plus hydrochlorothiazide (Avalide, Bristol-Myers Squibb) for ...
Combination therapy using irbesartan and hydrochlorothiazide was shown to effectively lower blood pressure levels in a large group of hypertensive patients. “The INCLUSIVE [Irbesartan/HCTZ blood ...
All batches of Irbesartan tablets in 75 mg, 150 mg and 300 mg strengths and Irbesartan and Hydrochlorothiazide tablets in 150 mg/12.5 mg and 300 mg/12.5 mg strengths made by Lupin Pharmaceuticals have ...
Clinical trials have shown that antihypertensive treatment with the angiotensin II receptor blocker (ARB) irbesartan is an effective way of lowering the BP, and the side effects are mild. 8 A number ...
The study was conducted in adult patients aged 18 years or older with moderate hypertension that at enrolment was either untreated for at least 4 weeks or uncontrolled by monotherapy. Monotherapy was ...
This combination medication contains angiotensin II receptor blocker and diuretic, prescribed for high blood pressure.
A drug company on Friday announced the recall of eight more lots of irbesartan blood pressure medication after testing revealed the drugs contained trace amounts of a carcinogen. Prinston ...
A drug company announced on Friday that eight lots of Irbesatan blood pressure medication have been recalled after testing showed the medication contained trace amounts of a cancer-causing material.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results